市場調査レポート

血液ガスおよび電解質分析装置市場分析:製品別、用途別 (血液ガス分析装置、電解質分析装置、複合分析装置) エンドユーザー別および2022年までのセグメント予測

Blood Gas And Electrolyte Analyzers Market Analysis By Product (Benchtop, Portable), By Application (Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers), By End-use (Clinical Laboratories, Point-of-Care) And Segment Forecasts To 2022

発行 Grand View Research, Inc. 商品コード 342356
出版日 ページ情報 英文 89 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
血液ガスおよび電解質分析装置市場分析:製品別、用途別 (血液ガス分析装置、電解質分析装置、複合分析装置) エンドユーザー別および2022年までのセグメント予測 Blood Gas And Electrolyte Analyzers Market Analysis By Product (Benchtop, Portable), By Application (Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers), By End-use (Clinical Laboratories, Point-of-Care) And Segment Forecasts To 2022
出版日: 2015年05月01日 ページ情報: 英文 89 Pages
概要

世界の血液ガスおよび電解質分析装置市場は2022年までに6億5,350万米ドルに達すると予測されています。ICUや救急救命の患者数増加と高処理の統合システムに対する需要拡大が市場成長を促進しています。また、世界的高齢化も市場成長に大きく貢献するとみられています。

当レポートでは、世界の血液ガスおよび電解質分析装置市場について分析し、製品別、用途別、エンドユーザー別見通しとともに、地域別動向などをまとめています。

第1章 調査方法と調査範囲

第2章 エグゼクティブサマリー

第3章 血液ガスおよび電解質分析装置業界見通し

  • 市場セグメンテーション
  • 市場規模と成長見通し
  • 市場動向
    • 促進因子
    • 阻害因子
  • 優先される主な機会
  • 業界分析:ポーターズ
  • PESTEL分析
  • バリューチェーン分析

第4章 製品別見通し

  • 製品別市場シェア:2014年、2022年
  • ベンチトップ血液ガスおよび電解質分析装置
  • ポータブル血液ガスおよび電解質分析装置

第5章 用途別見通し

  • 用途別市場シェア:2014年、2022年
  • 血液ガス分析装置
  • 電解質分析装置
  • 複合分析装置

第6章 エンドユーザー別見通し

  • エンドユーザー別市場シェア:2014年、2022年
  • 中央試験所市場
  • ポイントオブケア市場

第7章 地域別見通し

  • 地域別市場シェア:2014年、2022年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合環境

  • Siemens
  • Medica
  • Roche
  • Erba
  • Nova Stat
  • Bayer
  • Radiometer Medical
  • Samsung Medison
  • Edan Instruments
  • OPTI Medical Systems Inc.
  • Alere Medical
  • Convergent Technologies
  • Dalko Diagnostics
  • Afford Medical Technologies
  • Accurex Biomedical Pvt. Ltd.

図表

目次

Global blood gas and electrolyte market is expected to reach USD 653.5 million by 2022. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Further key findings from the study suggest:

Portable analyzers dominated the market with a share of over 60.0% in 2014 and are also expected to witness lucrative growth over the forecast period. Growing demand for automated, self-monitoring, portable devices, shorter analysis time, and quick accurate results are key factors boosting the growth of this segment.

Combined blood gas and electrolyte analyzers are expected to rapidly gain market share over the forecast period. Rising need for analyzers, which can analyze blood and electrolyte samples together are swiftly gaining popularity among users.

North America accounted for more than 40% of the blood gas and electrolyte analyzers market in 2014. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.

Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.

Key players of the blood gas and electrolyte analyzers market include Siemens, Medica, Roche, Nova Stat, Bayer, Radiometer Medical, Convergent technologies, Dalko Diagnostics, Afford Medical Technologies, and Accurex Biomedical Pvt. Ltd.

For the purpose of this study, Grand View Research has segmented the blood gas and electrolyte analyzers market on the basis of products, application, end-use, and region:

Global Blood Gas and Electrolyte Analyzers Market, Product Outlook (Revenue, USD Million, 2012 - 2022)

  • Benchtop
  • Portable

Global Blood Gas and Electrolyte Analyzers Market, Application Outlook (Revenue, USD Million, 2012 - 2022)

  • Blood gas analyzers
  • Electrolyte analyzers
  • Combined analyzers

Global Blood Gas and Electrolyte Analyzers Market, End-use Outlook (Revenue, USD Million, 2012 - 2022)

  • Clinical laboratories
  • Point-of-care

Blood Gas and Electrolyte Analyzers Market, Regional Outlook (Revenue, USD Million, 2012 - 2022)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Spain
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa

Table Of Contents

Chapter 1: Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2: Executive Summary

Chapter 3: Blood Gas And Electrolyte Analyzers Industry Outlook

  • 3.1. Market Segmentation
  • 3.2. Market size and growth prospects
  • 3.3. Blood gas and electrolyte analyzers-Market dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Introduction of technological advancements
      • 3.3.1.2. Growing global geriatric population base
      • 3.3.1.3. Increasing demand for high throughput and integrated system
      • 3.3.1.4. Growing prevalence of chronic diseases
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High prices of analyzers
      • 3.3.2.2. Presence of complicated regulatory framework
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry Analysis-Porter's
  • 3.6. Blood gas and electrolyte analyzers-PESTEL Analysis
  • 3.7. Global blood gas and electrolyte analyzers-Value chain analysis

Chapter 4: Blood Gas and Electrolyte Analyzers Product outlook

  • 4.1. Blood gas and electrolyte analyzers market share by product, 2014 & 2022
  • 4.2. Benchtop blood gas and electrolyte analyzers
    • 4.2.1. Portable blood gas and electrolyte analyzers
    • 4.2.2. Portable blood gas and electrolyte analyzers market, 2012-2022(USD Million)

Chapter 5: Blood Gas and Electrolyte Analyzers Application Outlook

  • 5.1. Blood gas and electrolyte analyzers revenue share by application, 2014 & 2022
  • 5.2. Blood gas analyzers market
  • 5.3. Blood gas analyzers market, 2012-2022(USD Million)
  • 5.4. Electrolyte analyzers market
  • 5.5. Electrolyte analyzers market, 2012-2022(USD Million)
  • 5.6. Combined analyzers
    • 5.6.1. Combined analyzers market, 2012-2022(USD Million)

Chapter 6: Blood Gas and Electrolyte Analyzers Market End-use Outlook

  • 6.1. Blood gas and electrolyte analyzers revenue share by end-use, 2014 & 2022
  • 6.2. Central laboratories market
    • 6.2.1. Central laboratories market, 2012-2022(USD Million)
  • 6.3. Point-of-care market
    • 6.3.1. Point-of-care market, 2012-2022(USD Million)

Chapter 7: Blood Gas and Electrolyte Analyzers Regional Outlook

  • 7.1. Blood gas and electrolyte analyzers market share, by region, 2014 & 2022
  • 7.2. North America
    • 7.2.1. North America market, by segment, 2012-2022(USD Million)
    • 7.2.2. U.S. market, by segment, 2012-2022(USD Million)
  • 7.3. Europe
    • 7.3.1. Europe market, by segment, 2012-2022(USD Million)
    • 7.3.2. Germany market, by segment, 2012-2022(USD Million)
    • 7.3.3. France market, by segment, 2012-2022(USD Million)
    • 7.3.4. Spain market, by segment, 2012-2022(USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific market, by segment, 2012-2022(USD Million)
    • 7.4.2. India market, by segment, 2012-2022(USD Million)
    • 7.4.3. China market, by segment, 2012-2022(USD Million)
    • 7.4.4. Japan market, by segment, 2012-2022(USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America market, by segment, 2012-2022(USD Million)
    • 7.5.2. Mexico market, by segment, 2012-2022(USD Million)
    • 7.5.3. Brazil market, by segment, 2012-2022(USD Million)
  • 7.6. MEA
    • 7.6.1. MEA market, by segment, 2012-2022(USD Million)
    • 7.6.2. South Africa market, by segment, 2012-2022(USD Million)

Chapter 8: Competitive Landscape

  • 8.1. Siemens
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Strategic Initiatives
  • 8.2. Medica
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Strategic Initiatives
  • 8.3. Roche
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Strategic Initiatives
  • 8.4. Erba
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Strategic Initiatives
  • 8.5. Nova Stat
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Strategic Initiatives
  • 8.6. Bayer
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Strategic Initiatives
  • 8.7. Radiometer Medical
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Strategic Initiatives
  • 8.8. Samsung Medison
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Strategic Initiatives
  • 8.9. Edan Instruments
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Strategic Initiatives
  • 8.10. OPTI Medical Systems Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Strategic Initiatives
  • 8.11. Alere Medical
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Strategic Initiatives
  • 8.12. Convergent Technologies
    • 8.12.1. Company Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Strategic Initiatives
  • 8.13. Dalko Diagnostics
    • 8.13.1. Company Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Strategic Initiatives
  • 8.14. Afford Medical Technologies
    • 8.14.1. Company Overview
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Strategic Initiatives
  • 8.15. Accurex Biomedical Pvt. Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
    • 8.15.4. Strategic Initiatives

List of Tables

  • TABLE 1: Blood Gas and Electrolyte Analyzers - Industry Summary & Buying Criteria
  • TABLE 2: Global market, by product, 2012 - 2022 (USD Million)
  • TABLE 3: Global market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 4: Global market, by application, 2012 - 2022 (USD Million)
  • TABLE 5: Global market, by region, 2012 - 2022 (USD Million)
  • TABLE 6: Blood gas and electrolyte analyzers - Key market driver analysis
  • TABLE 7: Blood gas and electrolyte analyzers - Key market restraint analysis
  • TABLE 8: Benchtop blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • TABLE 9: North America market, by product, 2012 - 2022 (USD Million)
  • TABLE 10: North America market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 11: North America market, by application, 2012 - 2022 (USD Million)
  • TABLE 12: U.S. market, by product, 2012 - 2022 (USD Million)
  • TABLE 13: U.S. market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 14: U.S. market, by application, 2012 - 2022 (USD Million)
  • TABLE 15: Europe market, by product, 2012 - 2022 (USD Million)
  • TABLE 16: Europe market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 17: Europe market, by application, 2012 - 2022 (USD Million)
  • TABLE 18: Germany market, by product, 2012 - 2022 (USD Million)
  • TABLE 19: Germany market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 20: Germany market, by application, 2012 - 2022 (USD Million)
  • TABLE 21: France market, by product, 2012 - 2022 (USD Million)
  • TABLE 22: France market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 23: France market, by application, 2012 - 2022 (USD Million)
  • TABLE 24: Spain market, by product, 2012 - 2022 (USD Million)
  • TABLE 25: Spain market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 26: Spain market, by application, 2012 - 2022 (USD Million)
  • TABLE 27: Asia Pacific market, by product, 2012 - 2022 (USD Million)
  • TABLE 28: Asia Pacific market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 29: Asia Pacific market, by application, 2012 - 2022 (USD Million)
  • TABLE 30: India market, by product, 2012 - 2022 (USD Million)
  • TABLE 31: India market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 32: India market, by application, 2012 - 2022 (USD Million)
  • TABLE 33: China market, by product, 2012 - 2022 (USD Million)
  • TABLE 34: China market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 35: China market, by application, 2012 - 2022 (USD Million)
  • TABLE 36: Japan market, by product, 2012 - 2022 (USD Million)
  • TABLE 37: Japan market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 38: Japan market, by application, 2012 - 2022 (USD Million)
  • TABLE 39: Latin America market, by product, 2012 - 2022 (USD Million)
  • TABLE 40: Latin America market, by end use, 2012 - 2022 (USD Million)
  • TABLE 41: Latin America market, by application, 2012 - 2022 (USD Million)
  • TABLE 42: Mexico market, by product, 2012 - 2022 (USD Million)
  • TABLE 43: Mexico market, by end use, 2012 - 2022 (USD Million)
  • TABLE 44: Mexico market, by application, 2012 - 2022 (USD Million)
  • TABLE 45: Brazil market, by product, 2012 - 2022 (USD Million)
  • TABLE 46: Brazil market, by end use, 2012 - 2022 (USD Million)
  • TABLE 47: Brazil market, by application, 2012 - 2022 (USD Million)
  • TABLE 48: MEA market, by product, 2012 - 2022 (USD Million)
  • TABLE 49: MEA market, by end use, 2012 - 2022 (USD Million)
  • TABLE 50: MEA market, by application, 2012 - 2022 (USD Million)
  • TABLE 51: South Africa market, by product, 2012 - 2022 (USD Million)
  • TABLE 52: South Africa market, by end-use, 2012 - 2022 (USD Million)
  • TABLE 53: South Africa market, by application, 2012 - 2022 (USD Million)

List of Figures

  • FIG. 1: Blood gas and electrolyte analyzers : Market segmentation
  • FIG. 2: Global blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 3: Blood gas and electrolyte analyzers : Market dynamics
  • FIG. 4: Global population growth, by age-group, 2012 - 2022 (Million)
  • FIG. 5: Regional breakdown: population over the age of 65 years, by region, 2010 & 2050
  • FIG. 6: Key Opportunities Prioritized
  • FIG. 7: Blood gas and electrolyte analyzers market - Porter's analysis
  • FIG. 8: Blood gas and electrolyte analyzers market - PESTEL analysis
  • FIG. 9: Global blood gas and electrolyte analyzers - Value Chain Analysis
  • FIG. 10: Blood gas and electrolyte analyzers market share by product, 2015 & 2022
  • FIG. 11: Global benchtop analyzers market, 2012 - 2022 (USD Million)
  • FIG. 12: Portable devices market, 2012 - 2022 (USD Million)
  • FIG. 13: Blood gas and electrolyte analyzers revenue share by application, 2014 & 2022
  • FIG. 14: Blood gas analyzers market, 2012 - 2022 (USD Million)
  • FIG. 15: Electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 16: Combined analyzers market, 2012 - 2022 (USD Million)
  • FIG. 17: Blood gas and electrolyte analyzers revenue share by end-use, 2015 & 2022
  • FIG. 18: Central laboratories market, 2012 - 2022 (USD Million)
  • FIG. 19: Point-of-care market, 2012 - 2022 (USD Million)
  • FIG. 20: Blood gas and electrolyte analyzers market share, by region, 2014 & 2022
  • FIG. 21: North America analyzers market, 2012 - 2022 (USD Million)
  • FIG. 22: U.S. blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 23: Europe analyzers market, 2012 - 2022 (USD Million)
  • FIG. 24: Germany blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 25: France blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 26: Spain blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 27: Asia Pacific analyzers market, 2012 - 2022 (USD Million)
  • FIG. 28: India blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 29: China blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 30: Japan blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 31: Latin America analyzers market, 2012 - 2022 (USD Million)
  • FIG. 32: Mexico blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 33: Brazil blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 34: MEA blood gas and electrolyte analyzers market, 2012 - 2022 (USD Million)
  • FIG. 35: South Africa analyzers market, 2012 - 2022 (USD Million)
Back to Top